From: Anti-tumor effect and mechanistic study of elemene on pancreatic carcinoma
Group | Dosage (μg/mL) | CV% (BxPC-3) | CV% (Panc-1) | ||||
---|---|---|---|---|---|---|---|
24 h | 48 h | 72 h | 24 h | 48 h | 72 h | ||
Control | – | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
Elemene | 15 | 87.2 ± 3.2* | 74.2 ± 3.0* | 65.7 ± 2.8* | 93.6 ± 3.3* | 81.1 ± 3.6* | 66.5 ± 2.7* |
30 | 57.7 ± 2.1** | 46.1 ± 2.4** | 41.7 ± 1.7** | 70.5 ± 2.5** | 59.3 ± 2.4** | 47.6 ± 1.8** | |
60 | 34.6 ± 2.0** | 22.7 ± 1.5** | 15.3 ± 0.9** | 54.7 ± 1.3** | 38.9 ± 0.8** | 26.8 ± 0.9** |